We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$271M
AUM Growth
+$12M
(+4.7%)
Cap. Flow
+$2.92M
Cap. Flow
% of AUM
1.08%
Top 10 Holdings %
Top 10 Hldgs %
46.48%
Holding
72
New
4
Increased
23
Reduced
28
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.83M |
| 2 |
CELG
Celgene Corp
CELG
|
+$817K |
| 3 |
Meta Platforms (Facebook)
META
|
+$708K |
| 4 |
Paycom
PAYC
|
+$464K |
| 5 |
PayPal
PYPL
|
+$456K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$678K |
| 2 |
Philip Morris
PM
|
+$344K |
| 3 |
AbbVie
ABBV
|
+$330K |
| 4 |
AT&T
T
|
+$302K |
| 5 |
CVS Health
CVS
|
+$258K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.44% |
| 2 | Technology | 21.21% |
| 3 | Communication Services | 10.8% |
| 4 | Consumer Staples | 10.77% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Honeywell
HON
$77B
| $508K | 0.19% |
3,902
+924
| +31% | +$123K |
|
52
ExxonMobil
XOM
$644B
| $492K | 0.18% |
5,929
-578
| -9% | -$46.1K |
|
53
Enbridge
ENB
$119B
| $470K | 0.17% |
13,050
-6,150
| -32% | -$195K |
|
54
Constellation Brands
STZ
$22.2B
| $392K | 0.14% |
1,788
-9
| -0.5% | -$2.03K |
|
55
Cisco
CSCO
$457B
| $383K | 0.14% |
8,908
-275
| -3% | -$12K |
|
|
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
| $373K | 0.14% |
4,840
-275
| -5% | -$20.6K |
|
57
Coca-Cola
KO
$377B
| $351K | 0.13% |
7,977
-300
| -4% | -$13K |
|
58
Eaton
ETN
$161B
| $327K | 0.12% |
4,356
+150
| +4% | +$11.6K |
|
59
Bristol-Myers Squibb
BMY
$133B
| $317K | 0.12% |
5,755
+1,000
| +21% | +$54K |
|
60
Emerson Electric
EMR
$83.9B
| $280K | 0.1% |
4,057
| – | – |
|
|
61
Philip Morris
PM
$297B
| $279K | 0.1% |
3,445
-4,050
| -54% | -$344K |
|
62
Amazon
AMZN
$2.92T
| $260K | 0.1% |
3,060
| – | – |
|
63
Target
TGT
$65.6B
| $222K | 0.08% |
2,925
| – | – |
|
64
IBM
IBM
$211B
| $221K | 0.08% |
1,647
| – | – |
|
65
UnitedHealth
UNH
$376B
| $221K | 0.08% |
+900
| New | +$216K |
|
66
ConocoPhillips
COP
$147B
| $217K | 0.08% |
+3,100
| New | +$207K |
|
67
DuPont de Nemours
DD
$18.5B
| $215K | 0.08% |
+1,287
| New | +$215K |
|
68
Imunon
IMNN
$6.68M
| $36K | 0.01% |
61
| – | – |
|
|
GCVRZ
69
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $5K | ﹤0.01% |
10,260
| – | – |
|
|
70
CVS Health
CVS
$133B
| – | – |
-4,160
| Closed | -$258K |
|
71
Kraft Heinz
KHC
$30.7B
| – | – |
-3,387
| Closed | -$210K |
|
|
72
AT&T
T
$159B
| – | – |
-11,118
| Closed | -$302K |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Dillon & Associates held 72 positions worth $271M, up 4.7% from $259M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Dillon & Associates's Q2 2018 filing shows 4 new, 23 increased, 28 reduced and 3 closed positions. Its largest new stake was NVIDIA: 301,040 shares worth $1.78M. The largest sale was Procter & Gamble, an estimated $678K.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.
- Dillon & Associates's largest Q2 2018 buy was NVIDIA: 301,040 shares worth $1.78M.
- Dillon & Associates added most to Celgene Corp in Q2 2018, an estimated $817K increase.
- Dillon & Associates's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $678K.
- Dillon & Associates fully exited AT&T in Q2 2018, selling an estimated $302K.
- Dillon & Associates's ten largest holdings make up 46% of its $271M portfolio in Q2 2018.
- Dillon & Associates opened 4 new positions and closed 3 in Q2 2018.
- Dillon & Associates's portfolio value rose 4.7% quarter-over-quarter to $271M.
Based on Dillon & Associates's 13F filing for Q2 2018, filed 8 Aug 2018.